WA-T-MOBILE
Today, T-Mobile (NASDAQ: TMUS) announced that Lucid Drone Technologies has chosen the Un-carrier to be the exclusive provider of IoT connectivity and management for their fleet of industrial spraying drones. Together, Lucid Drone Technologies and T-Mobile are collaborating to put maintenance teams and exterior cleaning companies out of harm’s way using drone technology for high-risk facilities maintenance work like exterior soft-wash cleaning and high-rise window washing. The companies also plan to leverage T-Mobile's industry-leading 5G network in the future to fly drones beyond line-of-sight and power more data-intensive capabilities like video streaming.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220424005109/en/
A game changer for safety of maintenance teams
Commercial property management firms and developers make significant investments to keep maintenance teams safe. Expensive liability insurance premiums and equipment fees have facilities leaders looking for new and cost-effective solutions. Enter industrial spraying drone pioneer Lucid Drone Technologies and the Un-carrier to deliver a game changer — drones equipped to clean exterior building surfaces and windows.
The next generation of Lucid Drone Technologies industrial spraying drones, powered by T-Mobile for Business, can perform exterior washing for commercial building surfaces and windows, including outdoor stadiums and arenas, hotels, and university structures. That means maintenance teams can steer clear of some high-risk tasks, keeping them safer and focused on other mission critical work.
IoT driving the future of industrial spraying drone technology
T-Mobile’s network powers critical capabilities for Lucid Drone Technologies industrial spraying drones such as real-time sharing of flight data, battery utilization information, hardware diagnostics, and delivery of firmware and software updates. Additionally, T-Mobile Control Center will give Lucid Drone Technologies the ability to view and manage the connectivity of their industrial spraying drones. With the automation and provisioning capabilities of T-Mobile’s IoT platform, Lucid Drone Technologies can easily accelerate deployment of their growing fleet. Lucid Drone Technologies will have near real-time visibility to all their industrial spraying drones with the ability to monitor network conditions and device behavior with T-Mobile Control Center.
Initially, T-Mobile for Business will deliver 4G LTE connectivity to Lucid Drone Technologies industrial spraying drones, providing a reliable connection nationwide. Lucid Drone Technologies expects to utilize the Un-carrier's 5G network in the near future for advanced use cases such as network operations center access, live streaming video and remote piloting. As Americas largest and fastest 5G network, T-Mobile is poised to push IoT to its full potential and catapult adoption — paving the way for new drone applications that rely on low-latency, high-speed data, and real-time location and proximity-based services.
"At Lucid Drone Technologies, we are committed to providing robotic solutions that allow our customers to complete jobs that were once dull, dirty, and dangerous in a safer, faster, and smarter way,” said Andrew Ashur, CEO, Lucid Drone Technologies. “T-Mobile not only allows us to provide our customers with the highest quality of real-time support and connectivity today, but they also have impressive 5G capabilities that allow us to push the frontier limits of responsible robotics."
“Lucid Drone Technologies is a great example of a customer using originality and new technology to solve complicated problems,” said Callie Field, President, T-Mobile Business Group. “It’s not very often that you get to collaborate with these kinds of thinkers, and we’re thrilled to have the opportunity to offer our technology to help bring their vision to life.”
To learn more about Lucid Drone Technologies, visit: www.luciddronetech.com
For more information about IoT from T-Mobile for Business, go to: www.t-mobile.com/business/solutions/iot
Follow T-Mobile’s Official Twitter Newsroom @TMobileNews to stay up to date with the latest company news.
Fastest based on median, overall combined 5G speeds according to analysis by Ookla® of Speedtest Intelligence® data 5G download speeds for Q1 2022. Ookla trademarks used under license and reprinted with permission.
About T-Mobile
T-Mobile U.S. Inc. (NASDAQ: TMUS) is America’s supercharged Un-carrier, delivering an advanced 4G LTE and transformative nationwide 5G network that will offer reliable connectivity for all. T-Mobile’s customers benefit from its unmatched combination of value and quality, unwavering obsession with offering them the best possible service experience and undisputable drive for disruption that creates competition and innovation in wireless and beyond. Based in Bellevue, Wash., T-Mobile provides services through its subsidiaries and operates its flagship brands, T-Mobile, Metro by T-Mobile and Sprint. For more information please visit: https://www.t-mobile.com .
About Lucid Drone Technologies
Lucid Drone Technologies is a Charlotte, NC-based robotics company that currently designs and builds industrial spraying drones for labor-intensive jobs. Lucid Drone Technologies was started in 2018, and set out to provide a Safer, Faster, and Smarter alternative to traditional dull, dirty, and dangerous jobs.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220424005109/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom